GENEOSCOPY
Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient’s least favorite screen: the colonoscopy. Currently, there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasive colonoscopy. Geneoscopy is changing that. It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples ... and detect changes in gene expression. This provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. Geneoscopy is currently developing a diagnostic test for the prevention of colorectal cancer and is conducting research on other applications of its technology for tangential indications.
GENEOSCOPY
Industry:
Biotechnology Genetics Health Care Health Diagnostics
Founded:
2015-01-01
Address:
Saint Louis, Missouri, United States
Country:
United States
Website Url:
http://www.geneoscopy.com
Total Employee:
11+
Status:
Active
Contact:
314-887-7777
Total Funding:
112.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Universal Analytics Euro Amazon Google Apps For Business GoDaddy DNS
Similar Organizations
Clinical Genomics Technologies
Clinical Genomics develops innovative products for colorectal cancer diagnosis.
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Board_member
Advisor
2017-01-01
Board_member
Advisor
Board_member
Current Employees Featured
Andrew Barnell Co-Founder and Chief Executive Officer @ Geneoscopy
Co-Founder and Chief Executive Officer
2015-02-01
Erica Barnell Co-founder, Chief Science Officer @ Geneoscopy
Co-founder, Chief Science Officer
2017-01-01
Eric Duncavage Chief Medical Officer @ Geneoscopy
Chief Medical Officer
2020-10-01
Haytham Gareer Chief Medical Officer @ Geneoscopy
Chief Medical Officer
2021-10-01
Founder
Investors List
Cultivation Capital
Cultivation Capital investment in Series B - Geneoscopy
BioGenerator
BioGenerator investment in Series B - Geneoscopy
Innovatus Capital Partners
Innovatus Capital Partners investment in Series B - Geneoscopy
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Geneoscopy
Lightchain
Lightchain investment in Series B - Geneoscopy
NT Asset
NT Asset investment in Series B - Geneoscopy
LabCorp
LabCorp investment in Series B - Geneoscopy
NT Asset
NT Asset investment in Series A - Geneoscopy
Lightchain
Lightchain investment in Series A - Geneoscopy
Cultivation Capital
Cultivation Capital investment in Series A - Geneoscopy
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-18 | Geneoscopy Appoints Dr. Haytham Gareer as Chief Medical Officer |
Official Site Inspections
http://www.geneoscopy.com Semrush global rank: 9.73 M Semrush visits lastest month: 114
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Geneoscopy"
About Us - Geneoscopy - Transforming Gastrointestinal Health
Geneoscopy was co-founded by the brother and sister team, Andrew (MBA) and Erica Barnell (MD/PhD). The idea for Geneoscopy was conceived during Dr. Erica Barnell’s first clinical …See details»
Geneoscopy - Crunchbase Company Profile & Funding
Geneoscopy is changing that. It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. This provides Geneoscopy a platform to harness …See details»
Our Leadership - Geneoscopy - Transforming Gastrointestinal Health
Geneoscopy co-founder, Erica Barnell graduated from Cornell University with a dual degree in Biological Sciences and Applied Economics & Management. Erica is an MD/PhD candidate at …See details»
Geneoscopy Company Profile 2025: Valuation, Funding
Geneoscopy General Information Description. Developer of a diagnostics technology designed to treat digestive diseases and also offer cancer screening services. The company's technology …See details»
Geneoscopy Information - RocketReach
Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA …See details»
Geneoscopy - LinkedIn
Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker ...See details»
Geneoscopy Company Profile: Overview and Full News Analysis
Geneoscopy, Inc. is a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health . Chief Executive Officer and Co-founder Andrew …See details»
Geneoscopy - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Geneoscopy . 2: obfuscated. …See details»
Geneoscopy Company Profile - Craft
Geneoscopy is a life sciences company focused on the development of diagnostic technologies that help to prevent, detect, and treat gastrointestinal disease. The company offers a …See details»
Geneoscopy - Updates, News, Events, Signals & Triggers
Geneoscopy has received FDA approval for its noninvasive colorectal cancer screening test, ColoSense. The company also expanded its leadership team to support the commercialization …See details»
Contact Us - Geneoscopy -Transforming Gastrointestinal Health
Get in touch with Geneoscopy.com for expert advice, support & inquiries about our cutting-edge genetic testing services. Contact us now! ... Organization. Email address . Message Topic. …See details»
Geneoscopy - Overview, News & Similar companies | ZoomInfo.com
Who is Geneoscopy. Geneoscopy Inc. is a life sciences company focused on the development of diagnostic tests for gastrointestinal health. Geneoscopy's lead diagnostic uses stool-derived …See details»
Geneoscopy Closes $105M in Series C Funding Round to Power …
Jan 8, 2025 ST. LOUIS & HERCULES, Calif., January 08, 2025--Geneoscopy raises $105 million in Series C funding round, led by Bio-Rad LaboratoriesSee details»
Geneoscopy - Contacts, Employees, Board Members, Advisors
Organization. Geneoscopy . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
Geneoscopy announces rebranding
Oct 4, 2022 RNA is the foundation of Geneoscopy’s patented technology – unique to Geneoscopy’s innovative stool-based diagnostics platforms. By using contrasting colors for the …See details»
Geneoscopy Closes $105M in Series C Funding Round to
Jan 8, 2025 Geneoscopy’s CEO, Andrew Barnell, will present a company update and expand on plans for this funding round at the 43rd Annual J.P. Morgan Healthcare Conference in San …See details»
Geneoscopy Locations - Contract Research Map
2220 Welsch Industrial Ct. Saint Louis, MO, 63146 United States Geneoscopy is a molecular diagnostics company committed to providing safe, effective, and innovative non-invasive tests …See details»
Geneoscopy Closes $105M in Series C Funding Round to Power
Jan 8, 2025 Geneoscopy’s ColoSense screening test is designed for use with Bio-Rad’s QXDx ddPCR platform and demonstrates remarkable sensitivity in detecting colorectal cancer and …See details»
Geneoscopy Closes $105M in Series C Funding Round to Power …
Jan 8, 2025 Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel …See details»
Geneoscopy’s Noninvasive Colorectal Cancer Screening Test …
Jan 10, 2023 Geneoscopy’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Although the Company believes that its …See details»